Nuvectis Pharma's total assets for Q2 2025 were $27.01M, a decrease of -10.42% from the previous quarter. NVCT total liabilities were $10.13M for the fiscal quarter, a 10.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.